DACH1 inhibits the proliferation and invasion of lung adenocarcinoma through the downregulation of peroxiredoxin 3. - Wikidata - wikimedia - TriplyDB

DACH1 inhibits the proliferation and invasion of lung adenocarcinoma through the downregulation of peroxiredoxin 3.

DACH1 inhibits the proliferation and invasion of lung adenocarcinoma through the downregulation of peroxiredoxin 3.

http://www.wikidata.org/entity/Q37188174

about

DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis.Effect of DACH1 on proliferation and invasion of laryngeal squamous cell carcinoma

P2860

Q52595632-7CB02670-0355-4059-8C63-444FAA8FC84D Q59128608-45EFDC78-EF7A-4B31-B7C8-8A6134CDEE90

P2860

DACH1 inhibits the proliferation and invasion of lung adenocarcinoma through the downregulation of peroxiredoxin 3.

http://www.wikidata.org/entity/Q37188174

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 January 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

DACH1 inhibits the proliferati ...... regulation of peroxiredoxin 3.

@en

DACH1 inhibits the proliferati ...... regulation of peroxiredoxin 3.

@nl

type

label

DACH1 inhibits the proliferati ...... regulation of peroxiredoxin 3.

@en

DACH1 inhibits the proliferati ...... regulation of peroxiredoxin 3.

@nl

prefLabel

DACH1 inhibits the proliferati ...... regulation of peroxiredoxin 3.

@en

DACH1 inhibits the proliferati ...... regulation of peroxiredoxin 3.

@nl

P1433

Q37188174-902A0D9A-B6CC-444F-892D-6618E4F3DA25

P1476

Q37188174-6F5DA822-DBA8-457D-B78F-B6F35D2A325D

P2093

Q37188174-0B7E9117-80C2-48BB-A2D9-89BCB5DC2BD2

Q37188174-10A141B6-9D39-4286-80CB-945C12E7ECA5

Q37188174-4B394ABC-2E61-40ED-B417-E73C412D6B58

Q37188174-A20FA8E8-E5EA-4AA2-AD1E-C21C45CC12C3

Q37188174-ACFC1DF3-D8BE-4DFC-A5BA-9A27E01CE9A1

Q37188174-C23B564D-93DB-43CD-9387-E23A45ABD03C

Q37188174-D58A95A5-3042-4EF2-A4E4-7F48C904C9FD

P2860

Q37188174-04011B23-31EC-4BDC-B1CB-0871B0D765D4

Q37188174-072B244C-6584-4A1D-B9D5-DDEFDF6431C9

Q37188174-1D53BE1F-89E9-403C-92B4-710BEA634551

Q37188174-28102133-B552-4765-BB99-1C391D7B5B6C

Q37188174-3482C07C-BC7F-449A-9405-F459D9EA839E

Q37188174-3D0338C3-6144-4037-919B-E0B6423EEFE8

Q37188174-53A03EB1-B7AA-4950-A370-E30F937B2A3E

Q37188174-55D4334F-9409-44A0-AE7D-73873998A3CF

Q37188174-60BD3DE3-F9EA-4E38-B80F-16182E13BF0F

Q37188174-7C510A2F-93F3-47FC-92D8-9D50AF7CB95B

P2888

Q37188174-8007D9BF-4371-41F6-875F-900026688256

P304

Q37188174-E2CC5F17-D551-4707-9652-AE1593DEC230

P31

Q37188174-BD5D75A1-4F87-45B9-B2C7-7782E23920DA

P356

Q37188174-CAA988ED-6361-463A-BCD9-A61CE4553D3D

P433

Q37188174-4E9198F6-21AB-4332-ADC7-201C2B3AF694

P478

Q37188174-3117ED14-DA84-41D8-BF9A-60D87329929B

P577

Q37188174-9A46A2B1-B660-4909-84E6-47022FD8E714

P5875

Q37188174-76F28980-810C-4FFE-B7E9-FC620EAD9957

P698

Q37188174-D0ACD31F-D291-427E-A61D-547DFB7134ED

P921

Q37188174-8D34892D-7E13-4073-B0E4-6D2C314886F6

P932

Q37188174-79A2B391-D21C-4160-BF67-9CB3804ADB24

P356

S13277-016-4811-X

P1433

P1476

DACH1 inhibits the proliferati ...... regulation of peroxiredoxin 3.

@en

P2093

Cong Wu

http://www.w3.org/2001/XMLSchema#string

Huafei Li

http://www.w3.org/2001/XMLSchema#string

Ji Zhu

http://www.w3.org/2001/XMLSchema#string

Jibin Xu

http://www.w3.org/2001/XMLSchema#string

Tiejun Zhao

http://www.w3.org/2001/XMLSchema#string

Xiaotian Wang

http://www.w3.org/2001/XMLSchema#string

Yang Yuan

http://www.w3.org/2001/XMLSchema#string

P2860

DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth

FoxM1, a critical regulator of oxidative stress during oncogenesis

Epidemiology of lung cancer

The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Global cancer statistics, 2012

Cancer statistics, 2015

Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors

Comparison of the efficacy and safety of EFGR tyrosine kinase inhibitor monotherapy with standard second-line chemotherapy in previously treated advanced non-small-cell lung cancer: a systematic review and meta-analysis

Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC)

P2888

s13277-016-4811-x

P304

9781-9788

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-016-4811-X

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291955232

http://www.w3.org/2001/XMLSchema#string

P698

26810067

http://www.w3.org/2001/XMLSchema#string

P921

P932

4990600

http://www.w3.org/2001/XMLSchema#string